ro7204239
mAbexperimental
Clinical trial activity
4 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
1
Phase 4
0
Earliest trial started Feb 14, 2022 (NCT05115110)
Timeline
Indications
Mechanism of action
- Growth/differentiation factor 8ANTAGONIST
myostatin
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07137585 | Phase 1 | Sep 30, 2025 | Roche |
| NCT06965413 | Phase 2 | May 5, 2025 | Roche |
| NCT05548556 | Phase 2 | Dec 20, 2022 | Roche |
| NCT05115110 | Phase 2/Phase 3 (Phase 3) | Feb 14, 2022 | Roche |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Roche | For profit | 4 | 4 | 3 | 2022 |
1 organizations
Page 1 / 1